Press releases
- AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
- AngioDynamics Receives 510(k) Clearance for AlphaVac F18⁸⁵ System in Treatment of PE
- AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
- AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
- AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
- AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
- AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
More ▼
Key statistics
On Tuesday, AngioDynamics Inc (UG2:STU) closed at 6.05, 26.04% above the 52 week low of 4.80 set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.80 |
---|---|
High | 6.05 |
Low | 5.80 |
Bid | 6.05 |
Offer | 6.25 |
Previous close | 5.85 |
Average volume | 444.44 |
---|---|
Shares outstanding | 40.05m |
Free float | 38.05m |
P/E (TTM) | -- |
Market cap | 260.76m USD |
EPS (TTM) | -4.78 USD |
Data delayed at least 15 minutes, as of Apr 16 2024.
More ▼